Phoslo and Promethazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Phoslo (calcium acetate) and Promethazine (promethazine hydrochloride). Common drug interactions include neuropathy peripheral among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Phoslo and Promethazine. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Phoslo?

Phoslo has active ingredients of calcium acetate. eHealthMe is studying from 4,291 Phoslo users. Check the latest studies of Phoslo.

What is Promethazine?

Promethazine has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 32,300 Promethazine users. Check the latest studies of Promethazine.



On Aug, 02, 2026

38 people who take Phoslo and Promethazine together, and have interactions are studied.

Phoslo and Promethazine drug interactions.

What are the common drug interactions of Phoslo and Promethazine, by gender? *:

female:

  1. Neuropathy peripheral (surface nerve damage)
  2. Osteomyelitis (infection of bone)
  3. Osteopenia (a condition where bone mineral density is lower than normal)
  4. Osteoporosis (bones weak and more likely to break)
  5. Oxygen saturation decreased
  6. Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
  7. Peripheral vascular disorder
  8. Postoperative wound infection
  9. Pulmonary oedema (fluid accumulation in the lungs)
  10. Purulent discharge (discharge that contains pus)

male:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Arthralgia (joint pain)
  5. Asthenia (weakness)
  6. Deformity (disfigurement)
  7. Depression
  8. Drug ineffective
  9. General physical health deterioration (weak health status)
  10. Haematocrit

What are the common drug interactions of Phoslo and Promethazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)

30-39:

  1. Nephrogenic anaemia (anaemia due to kidney disease)
  2. Renal failure (kidney dysfunction)
  3. Chronic kidney disease
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Glomerulonephritis membranoproliferative (a type of glomerulonephritis caused by deposits in the kidney glomerular mesangium and basement membrane (gbm) thickening)
  6. Hospitalisation
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Anxiety
  9. Arthralgia (joint pain)
  10. Asthenia (weakness)

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Drug ineffective
  4. Haematocrit
  5. Haemoglobin decreased
  6. Nephrogenic anaemia (anaemia due to kidney disease)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Anxiety
  9. Death
  10. Depression

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Renal injury (kidney injury)
  6. Anxiety
  7. Pain
  8. Nephropathy (damage to or disease of a kidney)
  9. Abdominal discomfort
  10. Constipation

60+:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Carotid artery stenosis (narrowing of carotid artery)
  4. Chest pain
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Dementia (madness)
  8. Drug effect decreased
  9. Drug intolerance (drug sensitivity)
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 18 people, 47.37%
  2. High Blood Pressure: 15 people, 39.47%
  3. Pain: 11 people, 28.95%
  4. Hiv Infection: 6 people, 15.79%
  5. Infection: 5 people, 13.16%
  6. Diabetes: 4 people, 10.53%
  7. Wheezing (a high-pitched whistling sound made while you breath): 3 people, 7.89%
  8. Multiple Allergies (allergy to multiple agents): 3 people, 7.89%
  9. Asthma: 3 people, 7.89%
  10. Bacterial Infection: 3 people, 7.89%

* Approximation only. Some reports may have incomplete information.

Do you take Phoslo and Promethazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Phoslo and Promethazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Phoslo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Promethazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phoslo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Promethazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on calcium acetate and promethazine hydrochloride (the active ingredients of Phoslo and Promethazine, respectively), and Phoslo and Promethazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: